Protocol summary

Study aim
comparing the levels of TSH, FT4, and FT3 in subclinical hypothyroid patients after treated with synbiotics versus placebo
Design
The present study is a randomized double-blind clinical trial study that will be conducted on 40 patients. Random allocation based on the table of random numbers, the synbiotic replacement blocks and its placebo will be divided into similar boxes.
Settings and conduct
In the present study, which will be conducted at Ali Bin Abi Taleb Hospital in Zahedan, 40 patients with subclinical hypothyroidism will be included in the study. treatment will generally be done within 8 weeks. The drug packages are completely similar in terms of shape and the patient and the plan administrator will not be aware of the contents of the packages. Fasting blood samples will be taken from these people before and after receiving the supplement or placebo to measure the level of thyroid hormones.
Participants/Inclusion and exclusion criteria
The inclusion criteria for this study are: age between 18 and 70 years The Exclusion criteria are: lack of consent of the patients to enter the study, suffering from thyroid nodule, cancer, any type of infection or inflammatory disease, coronary artery disease, heart failure, gastrointestinal diseases, pregnancy, smoking addiction. and alcohol and antibiotic use in the last 3 monthes.
Intervention groups
After 8 weeks from the start of treatment (taking one synbiotic or placebo pill per day), TSH, FT4, anti tpo and FT3 tests are evaluated in both intervention and control groups.
Main outcome variables
TSH, FT4, FT3 and Anti Tpo; Time to evaluate thyroid tests in patients; Subclinical hypothyroid patients treated with probiotics and patients treated with placebo

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20221124056594N1
Registration date: 2023-02-06, 1401/11/17
Registration timing: prospective

Last update: 2023-02-06, 1401/11/17
Update count: 0
Registration date
2023-02-06, 1401/11/17
Registrant information
Name
Maryam Pourmorteza
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 54 3348 2233
Email address
shnosratzehi123@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-02-19, 1401/11/30
Expected recruitment end date
2023-07-05, 1402/04/14
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison the effect of Synbiotics versus Placebo in Subclinical hypothyroid patients
Public title
effect of Synbiotics in Subclinical hypothyroid patients
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Confirmation of clinical hypothyroidism based on laboratory tests of TSH, T3, T4 and Anti-TPO and confirmation of an endocrinologist Lack of indication for treatment with levothyroxine
Exclusion criteria:
Having a thyroid nodule cancer Having any type of infection or inflammatory disease Absence of gastrointestinal diseases pregnancy Addiction to smoking, alcohol Use of antibiotics in the last 3 months
Age
From 18 years old to 70 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Data analyser
Sample size
Target sample size: 40
More than 1 sample in each individual
Number of samples in each individual: 2
Fasting blood sample to measure thyroid hormone levels
Randomization (investigator's opinion)
Randomized
Randomization description
Random assignment of patients to two groups is done by permuted block stratified randomization method. In this way, first, eligible referring patients are classified according to age and gender in the order of entry. Then they are assigned to the desired group based on blocks of 4 (consisting of two groups A and B and two repetitions for each) randomly selected from among all the possible states of permutations. These blocks were created using statistical software R version 4.0.2.
Blinding (investigator's opinion)
Double blinded
Blinding description
Double blinding method is used in this research. So that the researcher and the subjects will not be aware of the intended intervention.Patients will be treated by the drug packages predetermined by the project supervisor. The drug packages are completely similar in terms of shape and the patient and plan executive will not be aware of the contents of the packages. In the data analysis stage, the analysis will be done by the project advisor and the project manager, who are not aware of the contents of the drug packages, and only the patient group (group 1 or 2) will be determined for data analysis. Therefore, according to this working method, from the stage of entering the patient in the study to the completion of the study, data collection and information analysis, the contents of the two drug groups are not known.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Zahedan University of Medical Sciences
Street address
Dr. Hasabi square
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9816743463
Approval date
2022-10-24, 1401/08/02
Ethics committee reference number
IR.ZAUMS.REC.1401.300

Health conditions studied

1

Description of health condition studied
Subclinical iodine-deficiency hypothyroidism
ICD-10 code
E02
ICD-10 code description
Subclinical iodine-deficiency hypothyroidism

Primary outcomes

1

Description
Thyroid Hormones
Timepoint
At the beginning of the study (before the start of the intervention) and eight weeks after the start of synbiotic
Method of measurement
Fasting blood sample to measure the level of thyroid hormones by chemiluminescence method

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: All people diagnosed with subclinical hypothyroidism are randomly divided into two intervention and control (placebo) groups. After 8 weeks from the start of treatment, both groups are evaluated. As a probiotic, the drug familact from the brand of Danesh Banian bio-fermentation company, made in Iran, is used. The synbiotic capsule will contain the following 7 freeze-dried probiotic strains. Lactobacillus casei, 2 x 109 CFU Lactobacillus acidophilus, 1.5 x 109 CFU Lactobacillus Rhamnosus, 2 x 108 CFU Lactobacillus bulgaricus, 2 x 1010 CFU Bifidobacterium Breve, 7 x 109 CFU BIFIDOBACTOCTOMICS
Category
Treatment - Drugs

2

Description
Control group: Placebo will be prepared from Danesh Bonyan bio-fermentation company, made in Iran. Placebo contains: 375 mg of starch, 22 mg of lactose, 1 mg of magnesium stearate, 1 mg of silicon dioxide and 1 mg of talc.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Aliebne Abitaleb hospital
Full name of responsible person
Maryam Pourmorteza
Street address
Highway KHalije Fars, Aliebne Abitaleb hospital
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9816743111
Phone
+98 54 3329 5570
Fax
+98 54 1341 1252
Email
mrymp200@gmail.com
Web page address
https://alihos.zaums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Zahedan University of Medical Sciences
Full name of responsible person
Nourmohammad Bakhshani
Street address
Dr. Hasabi Square, Medical Sciences Pardis
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9816743463
Phone
+98 54 3337 2151
Email
mrymp200@gmail.com
Web page address
http://zaums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Zahedan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Zahedan University of Medical Sciences
Full name of responsible person
Maryam Pourmorteza
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Internal Medicine
Street address
Danesh 23 Street
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9816144673
Phone
+98 54 3348 2233
Email
shnosratzehi123@gmail.com
Web page address
http://zaums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Zahedan University of Medical Sciences
Full name of responsible person
Maryam Pourmorteza
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Internal Medicine
Street address
Danesh 23 Street
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9816144673
Phone
+98 54 3348 2233
Email
shnosratzehi123@gmail.com
Web page address
http://zaums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Zahedan University of Medical Sciences
Full name of responsible person
Maryam Pourmorteza
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Internal Medicine
Street address
Danesh 23 Street
City
Zahedan
Province
Sistan-va-Balouchestan
Postal code
9816144673
Phone
+98 54 3348 2233
Email
shnosratzehi123@gmail.com
Web page address
http://zaums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...